Nachrichten zur Exact Sciences Corp Aktie

Exact Sciences to participate in J.P. Morgan Healthcare Conference

MADISON, Wis., Jan. 3, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic…

Form 8-K EXACT SCIENCES CORP For: Dec 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test

MADISON, Wis., Dec. 20, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic…

Exact Sciences (EXAS) Crossed Above the 200-Day Moving Average: What That Means for Investors

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?...…

BeyondSpring, Exact Sciences top healthcare gainers; Synaptogenix, BiondVax among losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about trading options or stock in Exact Sciences, Alibaba, Winnebago, Apple, or Etsy?

NEW YORK, Dec. 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXAS, BABA, WGO, AAPL, and ETSY. Click…

Premarket Movers: Exact Sciences, Adobe, Deckers Outdoor

Premarket Movers: Exact Sciences, Adobe, Deckers Outdoor...…

Stocks to Watch: Adobe, Agrify, Guardant Health, Exact Sciences

Stocks to Watch: Adobe, Agrify, Guardant Health, Exact Sciences...…

Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study results

Shares of Guardant Health Inc. tanked 40% and shares of Exact Sciences Corp. rallied more than 25% in…

How Much Upside is Left in Exact Sciences (EXAS)? Wall Street Analysts Think 34%

The consensus price target hints at a 34.5% upside potential for Exact Sciences (EXAS). While empirical research shows that this…

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

MADISON, Wis., Dec. 9, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic…

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence…

China Biopsy Market Report to 2027 - Featuring Thermo Fisher Scientific, Bio-Rad Laboratories, Exact Sciences, Biocept, Biocartis and Roche Diagnostics Among Others

DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "China Biopsy Market, Volume, Size, Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation,…

Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 44%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 43.9% in Exact Sciences (EXAS).…

Exact Sciences (EXAS) Q3 Earnings Top Estimates, Margin Falls

Exact Sciences (EXAS) registers robust revenues from the Screening and Precision Oncology segments in Q3....…

Why Exact Sciences Stock Is Soaring Today

Investors are reacting positively to the companys Q3 update....…

Exact Sciences (EXAS) Q3 2022 Earnings Call Transcript

EXAS earnings call for the period ending September 30, 2022....…

Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 23.64% and 4.45%, respectively, for the quarter ended September 2022. Do…

Form 10-Q EXACT SCIENCES CORP For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exact Sciences GAAP EPS of -$0.84 beats by $0.23, revenue of $523.07M beats by $19.95M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exact Sciences to participate in November investor conferences

MADISON, Wis., Nov. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic…

Exact Sciences Earnings: The Most Important Metric to Watch

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Data presentations include positive impact of eliminating patient cost for follow-up colonoscopies, shifting to non-invasive colorectal cancer testing, and increasing…